Axio BioPharma Introduces New Protein Manufacturing Services
Axio BioPharma specializes in research-grade manufacturing of monoclonal antibodies (mAbs), focusing on small-scale production ranging from 50?mL to 2?L.
Axio BioPharma | 23/09/2024 | By Aishwarya | 115
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy